Evidence map›Paper›PMID 25303100›Full record

ArticlePloS one2014

Plasma cytokine profile in tropical endomyocardial fibrosis: predominance of TNF-a, IL-4 and IL-10.

Aline S Bossa, Vera M C Salemi, Susan P Ribeiro, Daniela S Rosa, Ludmila Rodrigues Pinto Ferreira, Suzete C Ferreira, Anna Shoko Nishiya, Charles Mady, Jorge Kalil, Edecio Cunha-Neto

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Bufei Huoxue Capsule Attenuates PM2.5-Induced Pulmonary Inflammation in Mice.Evidence-based complementary and alternative medicine : eCAM · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Aline S BossaLaboratory of Immunology, Heart Institute (InCor), University of São Paulo School of Medicine, São Paulo, Brazil; Division of Clinical Immunology and Allergy, University of São Paulo School of Medicine, São Paulo, Brazil.
Vera M C SalemiCardiomyopathy Unit, Heart Institute (InCor), University of São Paulo School of Medicine, São Paulo, Brazil.
Susan P RibeiroDivision of Clinical Immunology and Allergy, University of São Paulo School of Medicine, São Paulo, Brazil.
Daniela S RosaDivision of Immunology, Department of Microbiology, Immunology and Parasitology-Federal University of São Paulo-UNIFESP, São Paulo, Brazil.
Ludmila Rodrigues Pinto FerreiraLaboratory of Immunology, Heart Institute (InCor), University of São Paulo School of Medicine, São Paulo, Brazil; Division of Clinical Immunology and Allergy, University of São Paulo School of Medicine, São Paulo, Brazil.
Suzete C FerreiraCardiomyopathy Unit, Heart Institute (InCor), University of São Paulo School of Medicine, São Paulo, Brazil.
Anna Shoko NishiyaPró-Sangue Foundation, São Paulo, Brazil; Institute for Investigation in Immunology (iii), INCT, São Paulo, Brazil.
Charles MadyCardiomyopathy Unit, Heart Institute (InCor), University of São Paulo School of Medicine, São Paulo, Brazil.
Jorge KalilLaboratory of Immunology, Heart Institute (InCor), University of São Paulo School of Medicine, São Paulo, Brazil; Division of Clinical Immunology and Allergy, University of São Paulo School of Medicine, São Paulo, Brazil.
Edecio Cunha-NetoLaboratory of Immunology, Heart Institute (InCor), University of São Paulo School of Medicine, São Paulo, Brazil; Division of Clinical Immunology and Allergy, University of São Paulo School of Medicine, São Paulo, Brazil.
Universidade de São Paulo · BRFundação Pró-Sangue Hemocentro de São Paulo · BRUniversidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe participation of immune/inflammatory mechanisms in the pathogenesis of tropical endomyocardial fibrosis (EMF) has been suggested by the finding of early blood and myocardial eosinophilia. However, the inflammatory activation status of late-stage EMF patients is still unknown. METHODOLOGY/PRINCIPAL

findingsWe evaluated pro- and anti-inflammatory cytokine levels in plasma samples from late stage EMF patients. Cytokine levels of Tumor Necrosis Factor (TNF)-α, Interferon (IFN)-γ, Interleukin (IL)-2, IL-4, IL-6, and IL-10 were assayed in plasma samples from 27 EMF patients and compared with those of healthy control subjects. All EMF patients displayed detectable plasma levels of at least one of the cytokines tested. We found that TNF-α, IL-6, IL-4, and IL-10 were each detected in at least 74% of tested sera, and plasma levels of IL-10, IL-4, and TNF-α were significantly higher than those of controls. Plasma levels of such cytokines positively correlated with each other. CONCLUSIONS/SIGNIFICANCE: The mixed pro- and anti-inflammatory/Th2circulating cytokine profile in EMF is consistent with the presence of a persistent inflammatory stimulus. On the other hand, the detection of increased levels of TNF-α may be secondary to the cardiovascular involvement observed in these patients, whereas IL-4 and IL-10 may have been upregulated as a homeostatic mechanism to buffer both production and deleterious cardiovascular effects of pro-inflammatory cytokines. Further studies might establish whether these findings play a role in disease pathogenesis.

Indexed as

AdultEndomyocardial FibrosisFemaleHumansInterferon-gammaInterleukin-10Interleukin-2Interleukin-4Interleukin-6MaleMiddle AgedTumor Necrosis Factor-alphaYoung AdultInterferon-gammaInterleukin-10Interleukin-2Interleukin-4Interleukin-6Tumor Necrosis Factor-alpha

Identifiers

PMID25303100
PMCPMC4193862
OpenAlexW2073991604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.